Cargando…
External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer
INTRODUCTION: The aim of this article was to evaluate the effectiveness of the Gleason grade groups (GGG) system on a group of Argentinian patients with prostate cancer (PC) who underwent radical prostatectomy (RP). MATERIAL AND METHODS: We retrospectively studied 262 patients who underwent RP betwe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407779/ https://www.ncbi.nlm.nih.gov/pubmed/32782833 http://dx.doi.org/10.5173/ceju.2020.0039 |
_version_ | 1783567683014361088 |
---|---|
author | Bengió, Rubén G. Arribillaga, Leandro Bengió, Verónica Epelde, Javier Cordero, Esteban Oulton, Guillermo Carrara, Santiago Arismendi, Esteban |
author_facet | Bengió, Rubén G. Arribillaga, Leandro Bengió, Verónica Epelde, Javier Cordero, Esteban Oulton, Guillermo Carrara, Santiago Arismendi, Esteban |
author_sort | Bengió, Rubén G. |
collection | PubMed |
description | INTRODUCTION: The aim of this article was to evaluate the effectiveness of the Gleason grade groups (GGG) system on a group of Argentinian patients with prostate cancer (PC) who underwent radical prostatectomy (RP). MATERIAL AND METHODS: We retrospectively studied 262 patients who underwent RP between 1996 and 2014. To determine the performance and validity of the GGG system, a Kaplan-Meier analysis and multivariate analysis with Cox proportional method were performed to evaluate biochemical recurrence, distance metastases and specific cancer mortality. The area under the curve (AUC) was calculated to compare new groups of degrees of the GGG system with the classical scheme of stratification into 3 groups. RESULTS: The median follow-up was 84 months. As the groups ascend, there is less confined organ disease (p <0.001) and greater extraprostatic extension (p <0.001), greater invasion of seminal vesicles (p <0.001) and greater lymph node involvement (p <0.001). The biochemical recurrence-free survival at 5 years was 68%, 55%, 22%, 9%, 0% of the 1–5 groups, respectively. Ten-years cancer-specific survival was 96%, 95%, 78%, 64%, 25% for group 1–5, respectively. In the multivariate analysis, the GGG system is presented as the only independent predictor of biochemical recurrence and specific cancer mortality. The AUC indicates that the GGG system has a higher prognostic discrimination compared to the classic 3-group system (6, 7, ≥8). CONCLUSIONS: The International Society of Urological Pathology (ISUP) GGG system is an independent predictor of biochemical recurrence and mortality from prostate cancer in patients treated with RP. The classification into 5 groups shows greater discrimination in the prognosis than the traditional Gleason classification. |
format | Online Article Text |
id | pubmed-7407779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Polish Urological Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-74077792020-08-10 External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer Bengió, Rubén G. Arribillaga, Leandro Bengió, Verónica Epelde, Javier Cordero, Esteban Oulton, Guillermo Carrara, Santiago Arismendi, Esteban Cent European J Urol Original Paper INTRODUCTION: The aim of this article was to evaluate the effectiveness of the Gleason grade groups (GGG) system on a group of Argentinian patients with prostate cancer (PC) who underwent radical prostatectomy (RP). MATERIAL AND METHODS: We retrospectively studied 262 patients who underwent RP between 1996 and 2014. To determine the performance and validity of the GGG system, a Kaplan-Meier analysis and multivariate analysis with Cox proportional method were performed to evaluate biochemical recurrence, distance metastases and specific cancer mortality. The area under the curve (AUC) was calculated to compare new groups of degrees of the GGG system with the classical scheme of stratification into 3 groups. RESULTS: The median follow-up was 84 months. As the groups ascend, there is less confined organ disease (p <0.001) and greater extraprostatic extension (p <0.001), greater invasion of seminal vesicles (p <0.001) and greater lymph node involvement (p <0.001). The biochemical recurrence-free survival at 5 years was 68%, 55%, 22%, 9%, 0% of the 1–5 groups, respectively. Ten-years cancer-specific survival was 96%, 95%, 78%, 64%, 25% for group 1–5, respectively. In the multivariate analysis, the GGG system is presented as the only independent predictor of biochemical recurrence and specific cancer mortality. The AUC indicates that the GGG system has a higher prognostic discrimination compared to the classic 3-group system (6, 7, ≥8). CONCLUSIONS: The International Society of Urological Pathology (ISUP) GGG system is an independent predictor of biochemical recurrence and mortality from prostate cancer in patients treated with RP. The classification into 5 groups shows greater discrimination in the prognosis than the traditional Gleason classification. Polish Urological Association 2020-05-09 2020 /pmc/articles/PMC7407779/ /pubmed/32782833 http://dx.doi.org/10.5173/ceju.2020.0039 Text en Copyright by Polish Urological Association http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Original Paper Bengió, Rubén G. Arribillaga, Leandro Bengió, Verónica Epelde, Javier Cordero, Esteban Oulton, Guillermo Carrara, Santiago Arismendi, Esteban External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer |
title | External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer |
title_full | External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer |
title_fullStr | External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer |
title_full_unstemmed | External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer |
title_short | External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer |
title_sort | external validation of the gleason grade group system in argentinian patients that underwent surgery for prostate cancer |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407779/ https://www.ncbi.nlm.nih.gov/pubmed/32782833 http://dx.doi.org/10.5173/ceju.2020.0039 |
work_keys_str_mv | AT bengiorubeng externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer AT arribillagaleandro externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer AT bengioveronica externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer AT epeldejavier externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer AT corderoesteban externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer AT oultonguillermo externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer AT carrarasantiago externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer AT arismendiesteban externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer |